Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,723,357 papers from all fields of science
Search
Sign In
Create Free Account
NSC 281272
Known as:
NSC-281272
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
fazarabine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion 1
H. Bailey
,
K. Tutsch
,
+4 authors
G. Wilding
2006
Corpus ID: 9425795
A phase I trial of fazarabine (araAC, l-0-D-arabinofuranosyl-5-azaeytusine, NSC 281272) administered as a 24-h continuous…
Expand
1993
1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer
N. Ben-Baruch
,
A. Denicoff
,
B. Goldspiel
,
J. O’Shaughnessy
,
K. Cowan
Investigational new drugs
1993
Corpus ID: 10386590
SummaryFazarabine (Arabinofuranosyl-5-azacytosine) is a synthetic pyrimidine nucleoside which combines the arabinose sugar of…
Expand
1983
1983
Furanosyl-5-azacytosine (nsc 281272). Abstr.
Robert L. Dion
,
H. N. Jayaram
,
David A. Cooney
,
Gurpreet S. Ahluwalia
,
D. D. Johns
1983
Corpus ID: 70546713